4-toluenesulfonamide has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, YS; He, Q; Kuang, AR; Liu, YQ | 1 |
| Li, HY; Li, MY; Meng, H; Zhang, JR; Zhou, SZ; Zhu, WL | 1 |
2 other study(ies) available for 4-toluenesulfonamide and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Puncture injection of para-toluenesulfonamide combined with chemoembolization for advanced hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Male; Necrosis; Prognosis; Punctures; Sulfonamides; Toluene; Treatment Outcome | 2012 |
[Dose-effect relationship of para-toluenesulfonamide for treatment of hepatocellular carcinoma in rats].
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Dose-Response Relationship, Drug; Necrosis; Rats; Rats, Sprague-Dawley; Sulfonamides; Toluene | 2008 |